Clinical Trial Update: A Study Looking at the Use of Biomarkers to Provide Early Indication of Acute Kidney Injury in Patients With Sepsis (Limiting AKI Progression In Sepsis) [NA]

View source ↗

Summary

BioMérieux's biomarker study to provide early indication of acute kidney injury in sepsis patients has been terminated. The study did not proceed to completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Sepsis
• Septic Shock

Snippet

Sponsor: BioMérieux | Conditions: Sepsis, Acute Kidney Injury | NA | Status: TERMINATED